{"id":56183,"date":"2023-04-25T13:05:30","date_gmt":"2023-04-25T11:05:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/"},"modified":"2023-04-25T13:05:30","modified_gmt":"2023-04-25T11:05:30","slug":"antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/","title":{"rendered":"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit"},"content":{"rendered":"
\n

TORONTO–(BUSINESS WIRE)–$ATBPF<\/a>–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its participation in the Precision in Clinical Trials Summit being held in Boston on May 1 \u2013 2, 2023. Dr. Joseph Stauffer, Antibe\u2019s Chief Medical Officer, will deliver a live presentation discussing Antibe\u2019s clinical program for otenaproxesul:<\/p>\n

<\/a><\/p>\n

\nDate:<\/b> Tuesday, May 2, 2023
\n
Time:<\/b> 12:00 noon (Eastern Time)
\n
Location:<\/b> Revere Hotel Boston Common<\/p>\n

\nAn invitation-only event that addresses the needs of organizations conducting clinical trials at a local and global level, the 20th PCT Boston Clinical Trials Summit is a unique platform for clinical trial experts to share information and discuss the latest innovations.<\/p>\n

\nAbout Antibe Therapeutics Inc.<\/b><\/p>\n

\nAntibe is a clinical-stage biotechnology company leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions. The Company\u2019s current pipeline includes assets that seek to overcome the gastrointestinal (\u201cGI\u201d) ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (\u201cNSAIDs\u201d). Antibe\u2019s lead drug, otenaproxesul, is in clinical development as a safer alternative to opioids and today\u2019s NSAIDs for acute pain. Antibe\u2019s second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company\u2019s next target is inflammatory bowel disease (\u201cIBD\u201d), a condition long in need of safer, more effective therapies. Learn more at antibethera.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nAntibe Therapeutics Inc.
\n
Christina Cameron
\n
VP Investor Relations
\n
+1 416-577-1443
\n
christina@antibethera.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its participation in the Precision in Clinical Trials Summit being held in Boston on May 1 \u2013 2, 2023. Dr. Joseph Stauffer, Antibe\u2019s Chief Medical Officer, will deliver a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56183","6":"format-standard","7":"category-industry"},"yoast_head":"\nAntibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its participation in the Precision in Clinical Trials Summit being held in Boston on May 1 \u2013 2, 2023. Dr. Joseph Stauffer, Antibe\u2019s Chief Medical Officer, will deliver a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-25T11:05:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230425005194\/en\/718346\/21\/ANTIBE-logo-RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit\",\"datePublished\":\"2023-04-25T11:05:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/\"},\"wordCount\":261,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005194\\\/en\\\/718346\\\/21\\\/ANTIBE-logo-RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/\",\"name\":\"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005194\\\/en\\\/718346\\\/21\\\/ANTIBE-logo-RGB.jpg\",\"datePublished\":\"2023-04-25T11:05:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005194\\\/en\\\/718346\\\/21\\\/ANTIBE-logo-RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005194\\\/en\\\/718346\\\/21\\\/ANTIBE-logo-RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/","og_locale":"en_US","og_type":"article","og_title":"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit - Pharma Trend","og_description":"TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, today announced its participation in the Precision in Clinical Trials Summit being held in Boston on May 1 \u2013 2, 2023. Dr. Joseph Stauffer, Antibe\u2019s Chief Medical Officer, will deliver a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-25T11:05:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230425005194\/en\/718346\/21\/ANTIBE-logo-RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit","datePublished":"2023-04-25T11:05:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/"},"wordCount":261,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230425005194\/en\/718346\/21\/ANTIBE-logo-RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/","url":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/","name":"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230425005194\/en\/718346\/21\/ANTIBE-logo-RGB.jpg","datePublished":"2023-04-25T11:05:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230425005194\/en\/718346\/21\/ANTIBE-logo-RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230425005194\/en\/718346\/21\/ANTIBE-logo-RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/antibes-chief-medical-officer-to-present-at-the-2023-precision-in-clinical-trials-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Antibe\u2019s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56183"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56183\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}